[Ip-health] Ip Watch: WHO Asserts Global IP And Health Strategy Progressing But Offers Few Details

[Jeffrey A. Williams]

Judit, Kaitlin, and all,

  This doesn't strike me as being very open and transparent in
terms of process here.  Please ask Malebona to outline in
detail what the process is, and what is specifically meant by
"formally recognized".


Judit Rius Sanjuan wrote:

> http://www.ip-watch.org/weblog/index.php?p=3D1241
>
> Intellectual Property Watch
> 25 September 2008
> WHO Asserts Global IP And Health Strategy Progressing But Offers Few
> Details
>
> By Kaitlin Mara
> Work is ongoing within the World Health Organization on a member-
> mandated global strategy on public health, innovation and intellectual
> property, a WHO official said Tuesday. But little information about
> that work has been forthcoming since the strategy was approved in May.
>
> The =93silence of the WHO doesn=92t mean we haven=92t been doing work,=94=
 said
> Malebona Precious Matsoso, who directs the WHO Department of Technical
> Cooperation for Essential Medicines, speaking at an informal seminar
> hosted by IQsensato on 23 September. =93We are cautious; we cannot
> communicate things that have not been formally recognised.=94
>
> Intended to be an informal discussion between different interested
> stakeholders, all event participants spoke for themselves and not for
> their governments or institutions.
>
> The event brought together speakers from the WHO, governments, and non-
> governmental organisations to discuss the global strategy, which puts
> into action years of work at the WHO on issues such as neglected,
> under-researched diseases disproportionately affecting the poor (IPW,
> WHO, May 2008).
>
> Matsoso compared the strategy to the Development Agenda at the World
> Intellectual Property Organization, saying it would inform many
> different programmes at WHO. WIPO last year passed a 45-point plan -
> currently being implemented - for ensuring developing country needs
> are met through the organisation=92s activities.
>
> But much work lies ahead on key decisions contained in the global
> strategy and plan of action. This includes assessing priority needs of
> developing countries in medical research and development, improving
> developing country capacity for R&D, and implementing alternative
> funding strategies to stimulate R&D.
>
> Matsoso said that the WHO had =93consciously identified those partners
> we think need to work with us=94 and that the organisation had had
> several meetings with different stakeholders.
>
> She later explained that many of these stakeholders were researchers,
> often in developing countries, as well as public health associations,
> doctors and distributors of medicines. These are people, she said,
> whose day-to-day work will be affected by WHO decisions but who may
> not understand the implications of those decisions. They often =93come
> back to us saying they need their own assemblies to assess=94 the
> document, she added.
>
> Matsoso also said the WHO is working on a =93matrix=94 detailing what
> activities mentioned in the global strategy already exist, what
> activities need scaling up, and what activities constitute new work,
> so that the organisation can decide out how to budget the programmes.
> =93We=92re hoping to finalise it soon and share it with you,=94 she said.
>
> The global strategy [pdf] tasks WHO with creating and financing a
> =93quick start programme=94 to =93begin immediately to implement the
> elements of the global strategy and plan of action=94 falling under its
> responsibility.
>
> =93There=92s no time to waste,=94 said Ambassador Tom Mboya Okeyo of Keny=
a,
> who was in the audience, =93we have had many meetings, but for the
> billions suffering we need to move away from meetings=94 and =93provide
> support for implementation.=94
>
> Keeping the =91Secret=92 in Secretariat
>
> But there has been concern from many sources in Geneva about the
> international health agency=92s tight-lipped policy on providing details
> or specifics on progress in the four months since the May World Health
> Assembly accepted the strategy.
>
> Of particular concern to many civil society groups is the creation of
> an expert working group to =93examine current financing and coordination
> of research and development, as well as proposals for new and
> innovative sources of financing to stimulate research and development.=94
>
> Nicoletta Dentico, an advisor to IQsensato, said it is =93important to
> know the names of the people=94 in the working group, and how they =93hav=
e
> been consulted, summoned, connected.=94
>
> The global strategy called the establishment of the working group
> =93urgent=94 and Elil Renganathan, executive secretary of WHO=92s
> Secretariat on Public Health Innovation and Intellectual Property, had
> expressed to Intellectual Property Watch in May the hope that the
> group would be operating within 2 to 3 months.
>
> But the WHO has kept mum on the status of the working group. Matsoso
> was only able to say that it was a director general-level decision,
> and that WHO Director General Margaret Chan would =93communicate in due
> course=94 information about the working group.
>
> But the bulk of the strategy, she said, is a =93member-state-driven
> process.=94
>
> Perspectives From Government and Civil Society
>
> Also on hand at the meeting were representatives from several WHO
> member governments and civil society groups that work on public health.
>
> Charles Clift of the UK Department for International Development
> (DFID), who headed the Commission on Intellectual Property Rights,
> Innovation and Public Health, which gave rise to the Intergovernmental
> Working Group on Public Health, Innovation, and Intellectual Property
> (IGWG) that led to the global strategy, said he had many concerns
> about the global strategy which were carried over from concerns about
> the IGWG.
>
> Chief among them is that document contains =93too many commitments, that
> are too weak and too vague,=94 Clift said. Progress indicators in the
> strategy are not measurable. There is a =93missing middle column=94 in th=
e
> plan of action, he said: there are actions to take on one side, and
> stakeholders on the other, but no detail on what needs to be done to
> meet objectives. A critical issue is finding new sustainable financing
> mechanisms, he said, which will be the responsibility of the expert
> working group and =93one of the most important outcomes=94 of the process=
.
>
> Peter Beyer from the Swiss Federal Institute of Intellectual Property
> (IPI) noted that =93most of the work lies in front of us=94 and that it
> was now necessary for stakeholders to =93analyse the recommendations
> addressed to them.=94 IPI had a =93high-level meeting on the
> implementation of the WHO strategy and action plan=94 earlier on 23
> September and plans to identify actions addressed to Switzerland.
>
> Also contributing was Rodrigo Estrela from the Brazilian mission to
> the UN, who said the promise of a =93more positive environment=94 for
> using flexibilities to rules on trade-related intellectual property
> and its strong declaratory statement as to the importance of WHO as a
> leader on health issues related to IP were notable achievements. In
> addition, Jeanne Tor de Tarl=E9 of the French mission noted that an
> added value of the strategy is that it groups normally independent
> stakeholders and has them all work in the same direction.
>
> Stephen Matlin from the Global Forum on Health Research noted that it
> takes time to build sustainable capacity for health research, and that
> WHO should work with the =93many potential partners already working on
> aspects of the problem,=94 including those in policy capacity building,
> monitoring and resource tracking.
>
> Chikosa Banda, a researcher at the University of Cambridge (UK), said
> during a public health study in Malawi he found people =93are very
> suspicious of researchers and research,=94 and that research priorities
> are inevitably determined by those who fund the programmes, and thus
> address =93what people elsewhere think are critical problems.=94 A key
> aspect of capacity building would be to get such nations to be able to
> address their own health concerns.
>
> Jamie Love of Knowledge Ecology International said that there needs to
> be an instrument to deal with =93global collective action problems=94 in
> research, and suggested that prizes could be used to reward those who
> give patents to patent pools, to incentivise volunteering.
>
> Kaitlin Mara may be reached at kmara@ip-watch.ch.
>
> Judit Rius Sanjuan
> Attorney
> Knowledge Ecology International / Essential Information
> www.keionline.org / www.cptech.org
> Phone: +1.202.332.2670, x18
>
> _______________________________________________
> Ip-health mailing list
> Ip-health@lists.essential.org
> http://lists.essential.org/mailman/listinfo/ip-health

Regards,

Spokesman for INEGroup LLA. - (Over 281k members/stakeholders strong!)
"Obedience of the law is the greatest freedom" -
   Abraham Lincoln

"Credit should go with the performance of duty and not with what is
very often the accident of glory" - Theodore Roosevelt

"If the probability be called P; the injury, L; and the burden, B;
liability depends upon whether B is less than L multiplied by
P: i.e., whether B is less than PL."
United States v. Carroll Towing  (159 F.2d 169 [2d Cir. 1947]
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D
Updated 1/26/04
CSO/DIR. Internet Network Eng. SR. Eng. Network data security IDNS.
div. of Information Network Eng.  INEG. INC.
ABA member in good standing member ID 01257402 E-Mail
jwkckid1@ix.netcom.com
My Phone: 214-244-4827